The Remineralization of Early Enamel Caries in Permanent Teeth

May 21, 2024 updated by: Sara Ahmed Fathy Mohamed, Tanta University

Clinical Evaluation of Biomimetic Self -Assembling Peptide (p11-4) in The Remineralization of Early Enamel Caries in Permanent Teeth

Evaluate clinically the remineralizing potential of self-assembling peptide ( P11-4) fluoride plus in early enamel carious lesions of permanent anterior teeth.

Study Overview

Detailed Description

Study design This study will be conducted as a randomized controlled clinical trial. Study setting The study will be carried out in the clinic of Pediatric Dentistry Department, Faculty of Dentistry, Tanta University.

Group assignment:

Fifty children will be randomly allocated using simple random table into two groups as follows:

  • Group I (study group): Teeth will be treated with self-assembling peptide (P11-4) fluoride plus varnish.
  • Group II (control group): Teeth will be treated with fluoride varnish.

Ethical consideration The purpose of the present study will be explained to both the parents and children and informed consents will be obtained as well as ascents from children .The researcher will be obligated to do dental treatment for every child according to his-her condition as compensation according to the guidelines on human research adopted by the Research Ethics Committee, Faculty of Dentistry, Tanta University.

Materials to be used in the study:

Materials Composition Manufacture Trade names

Fluoride varnish

5% sodium fluoride (22.600ppm) Dentkist-korea Charm varnish R

Self-assembling peptide p11-4 Sodium Fluoride 0.05% Water,Chlorhexidine digluconate,Tromethamine, Trehalose Dihydrate, Oligopeptide-104, HydroxyPropyl MethylCellulose,Citric Acid,Sodium Hydroxide Credentis AG, Windisch, Switzerland CURODONT Repair ™ fluoride plus Polishing paste fluoride free Titanium Oxide Crosstex- Chicago,US Sparkle Free Prophy Paste

Methods

  1. Clinical examination and assessments:

    • Full dental and medical history for the children will be recorded in the child chart.
    • Children will be examined under reflector light conditions using sterile mirrors and blunt end probes with compressed air.
    • Labial surface of one anterior tooth in each child will be cleaned and plaque debris will be removed using a prophylaxis paste fluoride free and a polishing brush 20,21,.
    • Early enamel carious Lesions will be assessed according to the International Caries Detection and Assessment System (ICDAS II; ranging between 1-3) and Laser fluorescence (LF) measurements DIAGNOdent* will be conducted and values will be recorded as baseline data22,23.
  2. Clinical procedure:

    • The selected teeth will be isolated with rubber dam.
    • The labile surface of the teeth will be gently cleaned and dried with air syringe.
    • In Group I: Self-assembling peptide (P11-4) fluoride plus will be applied according to the manufacturer's instructions by pushing the two cylinders together and will left for 5 min till the tooth surface appears dry to insure its diffusion 15.
    • In Group II: Fluoride varnish will be applied under manufacturer instructions by applying thin layer of varnish with a brush in strokes 24.

    In all groups children will be advised to:

    • Not to rinse his or her mouth, eat, or drink for at least 30 minutes after the treatment, only soft food and drink can be consumed in the day of treatment 22.
    • The children use a soft toothbrush and fluoridated toothpaste as an oral hygiene regimen23.
  3. Evaluation:

The remineralizing process of the early enamel carious lesions will be assessed qualitatively using ICDAS II scoring system (table 1) and quantitatively using the laser fluorescence DIAGNOdent measuring at baseline 1, 3, 6 months post-treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Tanta, Egypt, 31511
        • Faculty of Dentistry,Tanta University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Presence of active non-cavitated carious white spot lesions with DIAGNO/dent reading from 5 to 17 ,on labial surfaces of permanent anterior teeth and International Caries Detection And Assessment System II (ICDAS II) ranging between 1 and 3.
  • The children' age range between 10 to14 years old.
  • Children had completed fixed orthodontic treatment within the past week.
  • Good oral hygiene with a plaque index score 0 or 1.
  • No systemic diseases or medication affecting salivary flow.

Exclusion Criteria:

  • Children with tetracycline pigmentation, dental fluorosis, or enamel hypoplasia.
  • Children had fluoride application less than 3 months before the study.
  • Presence of restoration and cavitation on the surface to be treated.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: fluoride varnish
Group II (control group): Teeth will be treated with fluoride varnish.
Fluoride varnish will be applied under manufacturer instructions by applying thin layer of varnish with a brush in strokes The remineralizing process of the early enamel carious lesions will be assessed quantitatively using the laser fluorescence DIAGNOdent measuring and assessed qualitatively using ICDAS II scoring system at baseline 1, 3, 6 months post-treatment
Other Names:
  • charm fluoride varnish
Experimental: curodont repair fluoride plus
Group I (study group): Teeth will be treated with self-assembling peptide (P11-4) fluoride plus varnish.

Self-assembling peptide (P11-4) fluoride plus will be applied according to the manufacturer's instructions by pushing the two cylinders together and will left for 5 min till the tooth surface appears dry to insure its diffusion

The remineralizing process of the early enamel carious lesions will be assessed quantitatively using the laser fluorescence DIAGNOdent measuring and assessed qualitatively using ICDAS II scoring system at baseline 1, 3, 6 months post-treatment

Other Names:
  • curodont repair fluoride plus varnish

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Remineralization potential
Time Frame: 1 month

T0:baseline assessment --> T1:1 month(Application of Curodont repair flouride plus /fluoride varnish andAssessment of white spot lesion regression)--> T2: 3 months Assessment of white spot lesion regression__>T3: 6 months assessment of white spot lesion regression by: Inspection under magnification ICDAS II Score 0:Sound tooth surface:

  1. First visual change in enamel.
  2. Distinct visual change in enamel visible when wet, lesion must be visible when dry.

by:Diagnodent

1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Remineralization potential
Time Frame: 3 months
[ Time Frame: T0:baseline assessment -->T1:1 month (Assessment of white spot lesion regression)--> T2:3 months(Application of Curodont repair flouride plus /fluoride varnish and Assessment of white spot lesion regression)--> T3: 6 months( Assessment of white spot lesion regression by Diagnodent , ICDASII
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 6, 2024

Primary Completion (Estimated)

November 6, 2024

Study Completion (Estimated)

January 6, 2025

Study Registration Dates

First Submitted

March 29, 2024

First Submitted That Met QC Criteria

April 5, 2024

First Posted (Actual)

April 10, 2024

Study Record Updates

Last Update Posted (Actual)

May 23, 2024

Last Update Submitted That Met QC Criteria

May 21, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

6 months

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on White Spot Lesion

Clinical Trials on self assembling peptide p11-4 with fluoride

Subscribe